Lou Donaldson, the alto saxophonist best known for as a “leading voice ... It was then that he also discovered his love of ...

Alto Neuroscience (NYSE:ANRO) shares nosedived 66% Wednesday morning, the first trading session, after the company announced its psychiatric drug ALTO-100 had failed a key clinical study. After ...

Levich is a board member for Bowman School, a private school in Palo Alto. She said she wants to promote dual enrollment and vocational training that will attract more students to the district and ...

Alto Neuroscience hit a bum note in an early test of its precision neuropsychiatry model. A phase 2b trial of Alto’s lead drug candidate in depression missed its primary and key secondary ...

Strong cash position expected to fund Alto’s planned operations through multiple near-term milestones across pipeline of independent programs – MOUNTAIN VIEW, Calif., October 22, 2024 ...